Stay updated on Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2. The study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-20T16:42:21.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T16:30:53.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with an added 403 HTML header and a Home link. This change replaces the previously visible study-record content and removes institution-specific references.
    Difference
    18%
    Check dated 2026-09-22T20:48:38.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.7.0 from v3.6.6, indicating a page version upgrade. This change is limited to the site’s versioning text and does not affect study details or user actions.
    Difference
    0.1%
    Check dated 2026-09-15T21:02:21.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.6, replacing v3.6.5, indicating a deployment or maintenance update. This change does not alter the study details visible to users.
    Difference
    0.1%
    Check dated 2026-09-01T18:13:39.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Removed the topic tags 'Prostate cancer' and 'MedlinePlus Genetics' from the page, removing related topics for indexing. This affects searchability and topic associations but does not change the study details themselves.
    Difference
    0.2%
    Check dated 2026-08-25T19:21:08.000Z thumbnail image

Stay in the know with updates to Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page.